LOXAPINE inhalation powder (AdasuveĀ®)
Clinical Indication
Rapid control of mild-moderate agitation in schizophrenia or bipolar disorder
Comments
Not yet reviewed
Date of classification
September 2016
Grey
Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.
- New medicines, devices, appliances.
- New indication of existing medicine.
- New NICE TA which has not been reviewed.
- Not been requested for review by either TAS/LPT MMC.